DRUG-ELUTING SINUS STENT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2017-06-21 for DRUG-ELUTING SINUS STENT manufactured by Intersect Ent.

Event Text Entries

[78128737] Although, the medical reviewer believed the event was not device-related, the event is being reported to be conservative. Intersect ent is reporting this event as an adverse event based on the information received and the remote possibility the complication was caused by use of the implant rather than merely correlated with its placement. Orbital cellulitis is an uncommon complication of sinusitis. Orbital complications from surgery typically occur intraoperatively or in the immediate postoperative period. The treating physician indicated that other than the radiographic appearance of the patient's sinuses, the patient's sinus exam did not seem to match the severity of her orbital symptoms. The instructions for use lists infection as a potential risk associated with use of the steroid-eluting sinus implant(s). The patient's weight is not known to the manufacturer. The physician could not recollect the model of the device used, was either propel (model 70011) or propel mini (model number 60011). Date of the implant was approximately 3 to 3? Weeks prior to the event. The following is being provided as this device is a combination product: name: propel or propel mini, dose, frequency & route used: (1) 370 ug implant, diagnosis for use: sinus surgery. Combination product -yes. Reference mfr report number 3008301917-2017-00009 for first implant in this bilateral case.
Patient Sequence No: 1, Text Type: N, H10


[78128738] Patient underwent bilateral total sphenoethmoidectomy, maxillary antrostomy as well as balloon sinuplasty of the frontal sinuses. Bilaterally steroid-eluting sinus implants were placed in the ethmoid cavities. Bioresorbable nasal packing product was placed within the implant on each side. No polyps or infection were encountered during surgery. Blood loss was minimal and the surgery was uneventful. Postoperatively, the patient was on 10 days of oral antibiotics and twice daily saline irrigations. Postoperative appointments were planned weekly. The first appointment reportedly went well. The patient missed her second appointment. Approximately 3 to 3? Weeks postoperatively the patient presented to the emergency room with right eye swelling, a ct was obtained and patient was diagnosed with a right preseptal orbital cellulitis. It was noted that the patient reported that her nose and sinuses felt very good. Endoscopy performed showed no clear evidence of mucopurulence or infection, there was no violation of the lamina, and the implants looked fine, with no evidence of adherent crusting. The patient improved rapidly on intravenous antibiotics and was eventually discharged to home without further medical or surgical intervention.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3008301917-2017-00010
MDR Report Key6659342
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2017-06-21
Date of Report2017-05-25
Date of Event2017-05-24
Date Mfgr Received2017-05-25
Date Added to Maude2017-06-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactAMY WOLBECK
Manufacturer Street1555 ADAMS DR
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal94025
Manufacturer Phone6506412115
Manufacturer G1INTERSECT ENT
Manufacturer Street1555 ADAMS DR
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal Code94025
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Generic NameDRUG-ELUTING SINUS STENT
Product CodeOWO
Date Received2017-06-21
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINTERSECT ENT
Manufacturer Address1555 ADAMS DR MENLO PARK CA 94025 US 94025


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2017-06-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.